NCT02089269View on ClinicalTrials.gov

Tumor Registry Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

2,325

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 14, 2022

Study Completion Date

June 30, 2024

Conditions
Pancreas Cancer
Trial Locations (1)

Unknown

iOMEDICO, Freiburg im Breisgau

All Listed Sponsors
lead

iOMEDICO AG

INDUSTRY

NCT02089269 - Tumor Registry Pancreatic Cancer | Biotech Hunter | Biotech Hunter